Latest From Biotech Now

Podcast: 2011 Dr. Paul Janssen Award winner Dr. Napoleone Ferrara

JOHNSON & JOHNSON DR. PAUL JANSSEN FOR BIOMEDICAL RESEARCH AWARD WINNER

Dr. Napoleone Ferrara, a Genentech Fellow, was named the 2011 winner of The Dr. Paul Janssen Award for Biomedical Research. Dr. Ferrrara was recognized for his research on angiogenesis, the process of new blood vessel formation, and the isolation and cloning of vascular endothelial growth factor (VEGF), a major regulator of angiogenesis in physiology and disease. Download the podcast

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

2011 BIO International Convention: The evolution of one-on-one partnering

businessforum

From the beginning, networking has been a central focus at BIO’s events.  Our members attend our conferences primarily to seek out business opportunities and to meet other biotech executives. When company presentations were introduced at the 1998 BIO International Convention, delegates registered for the conference by mail and fax and presentations were the key means for companies to tell their stories at BIO’s early events.  With BIO members asking for introductions to pharmaceutical companies, BIO Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , ,

Counterfeiting: White House IP Czar Victoria Espinel on working with corporations

Victoria Espinel

White house IP Czar Victoria Espinel spoke at BIO’s 2011 International Convention in a session titled Counterfeiting: How corporations and government can work together.  She told the audience that when entering her new assignment she was surprised to find out that counterfeiting was a large problem in the United States and not just abroad. The Administration has increased enforcement in counterfeit medicines as seizures of health related counterfeits have gone up 97% from last year.  Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Innovative China: Policies for the Future

China Flag

As the second largest and fastest growing market for biotechnology products, China needs no introduction.  The opportunity to heal, fuel, and feed 1.3 billion global citizens stands in clear contrast with the regulatory, financial, and political frameworks that present challenges to the life science industry’s external access to the evolving Chinese market.  On Tuesday at the 2011 BIO International Convention, a panel discussion titled “Innovative China: Policies for the Future” addressed the future of the Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Current Challenges in Payment Reform

By Alyson Pusey, BIO. The Affordable Care Act created several demonstration projects to test innovative care delivery systems that increase quality of care while decreasing costs.  Speaking as a panelist was Jonathan Blum, Deputy Administrator and Director of the Center for Medicare at CMS, who discussed how the agency is thinking about payment reform.  Evidenced by the recent proposed rule on accountable care organizations (ACOs), the agency is looking to providers and the health care Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , ,